Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Athira Pharma, Inc. (ATHA) had Stock-Based Compensation of $3.23M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.97M |
|
-- |
|
-- |
|
$7.29M |
|
$-7.29M |
|
$0.33M |
|
$-6.97M |
|
$-6.97M |
|
$-6.97M |
|
$-6.97M |
|
$-6.97M |
|
$-6.97M |
|
$-7.29M |
|
$-7.17M |
|
3.91M |
|
3.91M |
|
$-1.80 |
|
$-1.80 |
|
| Balance Sheet Financials | |
$32.22M |
|
$1.96M |
|
$3.33M |
|
$35.55M |
|
$2.98M |
|
-- |
|
$0.58M |
|
$3.56M |
|
$31.99M |
|
$31.99M |
|
$31.99M |
|
3.94M |
|
| Cash Flow Statement Financials | |
$-21.66M |
|
$-6.91M |
|
$0.02M |
|
$49.07M |
|
$20.52M |
|
$-28.55M |
|
|
Stock-Based Compensation |
$3.23M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.78% |
|
-21.78% |
|
-19.60% |
|
-21.78% |
|
$8.11 |
|
$-5.54 |
|
$-5.54 |
|